GDNF was discovered as a secretion product from the rat B49 glioma cell line in 1993 and was suggested to be the innovative therapy for Parkinson’s symptoms since it protected the midbrain dopaminergic neurons from oxidative stress and other injuries and controlled microglial reactivity [106]. The gene discussed is GDNF; the disease is Parkinson disease.